This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
AI drug development start-up BioXcel Therapeutics nets $55.8mm in IPO
BioXcel Therapeutics Inc. (artificial intelligence (AI) platform to identify neuro and immuno-oncology drugs) netted $55.8mm in its initial public offering of 5.45mm shares at $11 (the low end of its anticipated $11-13 range for 5mm shares).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?